Dr David Austin is a Consultant Cardiologist at The James Cook University Hospital, Middlesbrough, South Tees NHS Foundation Trust and Honorary Senior Clinical Lecturer at Newcastle University, UK.Dr Austin is founder and co-director of the Academic Cardiovascular Unit at South Tees (https://www.southtees.nhs.uk/about/strive/research-team/academic-cardiovascular-unit/) and has established grant. In this webinar he discusses The Prospective Randomized On-X Valve Anticoagulation Clinical Trial (PROACT) with special consideration for its impact on cardio-oncology care.
To veiw the entire webinar go to: https://www.radcliffecardiology.com/webinars/ic-os-journal-club-proact-trial-and-reflections-cardio-protection-trials
Dr. Khattab completed his cardio-oncology and advanced cardiac imaging fellowship at Yale University School of Medicine. He currently practices at St Francis Heart and Vascular Institute in Tulsa, OK, USA, and as an assistant professor for Oklahoma State University Cardiovascular Disease fellowship and serves as director of cardio-oncology there. In this episode he discusses radiation induced heart disease, diagnosis and management.
IC-OS President Dr. Susan Dent & treating physician Dr. Ana Barac speak with cancer survivor and patient advocate Julia Maués about her experiences. Join us for an inspiring story of survival and hope.
For more information about Julia's advocacy work go to: https://graspcancer.org/
Kerry Skurka’s professional career was as a nurse in cardiology, and after her own cancer experience she moved to oncology. While caring for cancer patients she saw cardiac symptoms routinely and therefore welcomed the opportunity to be the first Cardio-Oncology Nurse Navigator at Franciscan Health in Indianapolis. Together with her cardio-oncologist Vijay Rao the program grew to 3 nurse navigators and 6 satellite clinics. During this time Kerry was given the opportunity to start the Nursing Workgroup within the International Cardio-oncology Society to grow the field of cardio-oncology nursing.
Losing both her husband and father to cancer, Kerry’s passion for this work continues. Currently, she works independently in the healthcare field sharing her knowledge and experience providing consultation for nurses and programs .
Yvonne Callahan Assistant Clinical Instructor, Missouri State University School of Nursing and an oncology nursing specialist.
Cezar Iliescu, MD is Professor, Department of Cardiology, and an Interventional Cardiologist, The University of Texas MD Anderson Cancer Center, Houston, TX
Dr. Iliescu has published extensively on the issue of managing pericardial disease in patients with cancer. Today he discusses pericardial effusions, pericardial tumors, pericarditis, and other related complications facing patients with cancer.
Dra Teresa López-Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain. She is specializes in cardiac imaging and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. Here we discuss risk stratification in cardio-oncology care.
In this episode recorded at the ACC Cardio-Oncology meeting in 2025 Dr. Addison discusses safeguarding the heart during stem cell transplantation: from pre-transplant CV evaluation to survivorship
Dr. Eric Chow is an expert in cancer survivorship. He focuses on survivors of childhood cancers and survivors of blood stem cell transplantation of all ages. In this discussion he addresses the various cardiovascular challenges survivors of childhood cancer face.
Kathryn J. Ruddy, M.D., studies long-term and late effects of cancer treatments, and how to best care for cancer survivors to enhance their quality of life and reduce symptoms. In this episode Dr. Ruddy discusses her session at the ACC meeting on cardioprotective strategies.
Darryl Leong is a leading researcher in genitourinary malignancies including prostate, bladder and renal cancers. The cardiovascular risks and complications for each are varied depending on the treatments involved. Dr. Leong discusses the risk profiles and management strategies for this population.
In this new series we will be highlighting the patient experience by speaking with patients and the physicians who treat them. We know you will be inspired by these stories in your own experience either as a patient or a health care provider.
Today we speak withLalitha C. Medepalli, MD, FACC, FASE, RPVINorthside Hospital, Atlanta, GA USA and her patient Karen Rowland.
Dr Alessandra Ferrajoli (University of Texas MD Anderson Cancer Center, US) provides an in-depth cumulative review of hypertension management in patients with Chronic Lymphocytic Leukemia (CLL) and other hematologic malignancies treated with Acalabrutinib. This podcast explores the mechanisms, incidence and clinical implications of treatment-related hypertension, offering evidence-based strategies to optimise cardiovascular care for this patient population.
Dr. Barac and Dr. Bloom were authors on a new scientific statement from the Heart Failure Society of America on Cardio-Oncology. In this episode they discuss highlights from this statement.
Dr. Ana Barac serves as the Medical Director of the Cardio-Oncology Program at Inova Health in Fairfax. VA in the Wash DC area. She is a Professor of Medicine at Georgetown University and her interests focus on advanced cardiovascular imaging.
Dr. Bloom is a professor in the Department of Medicine and a member of the Division of Cardiology at NYU Grossman Long Island School of Medicine.
A renowned expert in cardio-oncology and heart failure, she joined New York University Langone Health as director of the Cardio-Oncology Program in 2023.
Jeff Sharman M.D. is the medical director of hematology research for the US Oncology / Sarah Cannon Research Institute network. This consortium manages approximately one out of every five cancer patients treated in the United States and is the largest private research network in the country.
Dr Sharman developed the original idea of using BTK inhibitors to treat lymphoid malignancies and conducted the first in human studies of ibrutinib within his private practice at the Willamette Valley Cancer and Research Center in Eugene, Oregon, US.
Here Dr. Sharman addresses hypertension and arrhythmias related to BTK inhibitors.
Dr. Alexis Vasbinder, University of Washington School of Nursing, Seattle, USA
Read her article here:
https://www.jacc.org/doi/10.1016/j.jaccao.2023.07.007
Atrial Fibrillation and Anticoagulation are complex matters in cancer care. Dr. Abdel-Qadir provides a masterful summary of the key issues in this episode.
Prof Husam Abdel-Qadir, MD, Phd is a Cardiologist at Women’s College Hospital, Toronto, CA. Prof Abdel-Qadir's primary clinical and research focus is on the cardiovascular health of people with cancer, particularly breast cancer and he leads a research programme on the management and outcomes of people with atrial fibrillation.
Dr. Gagan Sahni Director of Cardio- Oncology and Inpatient Cardiology Consult services at Mount Sinai Hospital in NYC, and Fellow of ICOS presents her Center of Excellence quality improvement project.
Anecita Fadol who is Associate Professor, Education Director- Nursing Cardiology Program · The University of Texas MD Anderson Cancer Center and chair of the ICOS nurses Working Group
Jessica Coviello, DNP, APRN(Ct), ANP-BC, FAAN, Associate Dean of Faculty Development, Professor, Graduate Studies, Univ of TX School of Nursing in Houston
Dr. Carrie Lennemam, University of Alabama Birmingham explains how they are using AI to expedite referrals to their cardio-oncology clinic, saving time and saving lives.
Dr. Eric Yang, Director of Cardio-Oncology discusses how they have integrated cardio-oncology training into all aspects of their program for residents and fellows.
